Hepatocellular carcinoma (HCC) is a common malignant tumor in the liver. Microvascular invasion (MVI) is one of the important risk factors affecting the recurrence and prognosis of HCC. Some scholars have predicted MVI through various imaging methods such as CT, MRI and PET, but has not yet reached a unified forecasting standard. Gadoxetate disodium（Gd-EOB-DTPA）is a novel hepatobiliary contrast agent. Peritumoral hypointension in hepatobiliary phase is of great value in predicting MVI, but the related studies are few. In this study, we used multiple parameters to analyze the value of Gd-EOB-DTPA enhanced MRI in predicting MVI qualitatively and quantitatively.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords